Grant: Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
McMaster University
$100,000.00
Identification of co-receptor or other host factors required for cellular entry of human coronavirus NL63 (HCoV-NL63)
FY 2008-09
Summary
Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by the SARS associated coronavirus (SARS-CoV). The outbreak of SARS in Canada and other countries in 2002-2003 had not only posed a series of challenges for the public health-care sectors, but also underscored the potential threat to the public health posed by novel coronaviruses. Human coronavirus NL63 (HCoV-NL63, NL63) has recently been identified in many countries including Canada. NL63 has been found to be associated with a variety of respiratory diseases, such as pneumonia. Viral entry into the host cells is the first and one of the most critical steps of the replication cycle of a virus. In coronaviruses, this entry step is mediated by the interaction between the viral surface spike (S) proteins and host cell receptors. Interestingly, both SARS-CoV and NL63 employ human angiotensin-converting enzyme 2 (hACE2) as a functional receptor for cellular entry despite huge differences in the severity of the human diseases caused by these two viruses. However, our recent studies have suggested that hACE2 receptor is not sufficient for the cellular entry of NL63, and hypothesized that a co-receptor or other host factors are required for the viral entry. In this study, we will employ some of the most powerful technologies to identify the putative co-receptor or other factors. Our study may help understand the molecular mechanisms responsible for the viral adaptation, interspecies transmission, and pathogenesis of HCoV-NL63 and SARS-CoV. It may also help identify new molecular targets for the development of novel therapeutic strategies and preventive vaccines against these viral pathogens.
Department
Program
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
178299
Name
Zhang Chengsheng
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Virology & Viral Pathogenesis
Projecttitle
Identification of co-receptor or other host factors required for cellular entry of human coronavirus NL63 (HCoV-NL63)
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Keyworddelim
Cdna Library; Co-Receptor; Hcov-Nl63; Receptor; Rna Interference; Sars-Cov
Abstract
Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by the SARS associated coronavirus (SARS-CoV). The outbreak of SARS in Canada and other countries in 2002-2003 had not only posed a series of challenges for the public health-care sectors, but also underscored the potential threat to the public health posed by novel coronaviruses. Human coronavirus NL63 (HCoV-NL63, NL63) has recently been identified in many countries including Canada. NL63 has been found to be associated with a variety of respiratory diseases, such as pneumonia. Viral entry into the host cells is the first and one of the most critical steps of the replication cycle of a virus. In coronaviruses, this entry step is mediated by the interaction between the viral surface spike (S) proteins and host cell receptors. Interestingly, both SARS-CoV and NL63 employ human angiotensin-converting enzyme 2 (hACE2) as a functional receptor for cellular entry despite huge differences in the severity of the human diseases caused by these two viruses. However, our recent studies have suggested that hACE2 receptor is not sufficient for the cellular entry of NL63, and hypothesized that a co-receptor or other host factors are required for the viral entry. In this study, we will employ some of the most powerful technologies to identify the putative co-receptor or other factors. Our study may help understand the molecular mechanisms responsible for the viral adaptation, interspecies transmission, and pathogenesis of HCoV-NL63 and SARS-CoV. It may also help identify new molecular targets for the development of novel therapeutic strategies and preventive vaccines against these viral pathogens.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhang, Chengsheng
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~